Hospital
Public Hospital District No 2 Skagit County Washington
Public Hospital District No 2 Skagit County Washington was paid $8.40M by Medicaid between Jan 2018 and Dec 2024, across 198 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 16% of everything it billed.
33Billing provider infoPUBLIC HOSPITAL DISTRICT NO 2 SKAGIT COUNTY WASHINGTON
ANACORTES, WA 98221
ANACORTES, WA 98221
33aNPI1710913140assigned 06/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.40M
24GClaims358,374
24DCodes billed198
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Washington
Rank by total paid#35 of 49
Median peer was paid$20.06M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,084 | $1.00M | |
| 2019 | 42,292 | $998K | |
| 2020 | 48,246 | $1.09M | |
| 2021 | 66,510 | $1.47M | |
| 2022 | 61,709 | $1.52M | |
| 2023 | 57,000 | $1.30M | |
| 2024incomplete | 42,533 | $1.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 16% | 4,873 | 3,963 | $1.31M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 10,256 | 9,519 | $1.11M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 9.9% | 11,516 | 9,471 | $834K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.9% | 10,140 | 9,032 | $748K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.4% | 2,326 | 2,175 | $451K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.7% | 3,351 | 3,183 | $391K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.1% | 7,173 | 6,610 | $262K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.8% | 10,726 | 3,564 | $237K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.5% | 1,848 | 1,732 | $210K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.4% | 2,331 | 1,671 | $200K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.4% | 4,526 | 1,443 | $200K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.2% | 1,677 | 1,570 | $185K |
186 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.8% | 1,266 | $150K |
| 59025 | Fetal non-stress test | 1.6% | 1,078 | $138K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.4% | 6,818 | $116K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.2% | 1,136 | $104K |
| 99285 | Emergency room visit (most serious) | 1.2% | 1,696 | $98K |
| 80053 | Comprehensive metabolic panel | 1.1% | 16,706 | $91K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 767 | $78K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,647 | $77K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,116 | $70K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 785 | $64K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,193 | $61K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 276 | $56K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 258 | $54K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,833 | $53K |
| 36415 | Collection of venous blood by venipuncture | <1% | 25,816 | $48K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,538 | $39K |
| Q3014 | Telehealth originating site facility fee | <1% | 2,385 | $38K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,987 | $35K |
| G0378 | Hospital observation service, per hour | <1% | 1,955 | $35K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 644 | $27K |
| 76830 | Ultrasound, transvaginal | <1% | 900 | $25K |
| 84484 | <1% | 3,773 | $24K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 325 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,105 | $21K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 229 | $21K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,341 | $21K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 270 | $21K |
| 80050 | General health panel | <1% | 2,289 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,301 | $20K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 89 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,498 | $18K |
| 87400 | <1% | 2,029 | $17K | |
| 80061 | Lipid panel | <1% | 4,190 | $17K |
| 73630 | <1% | 830 | $17K | |
| 73562 | <1% | 816 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,313 | $16K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,214 | $15K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,401 | $15K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,074 | $15K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,429 | $15K |
| 83605 | <1% | 2,482 | $15K | |
| 84145 | <1% | 1,402 | $14K | |
| 84439 | <1% | 2,155 | $14K | |
| 87070 | <1% | 3,327 | $14K | |
| 97113 | <1% | 204 | $13K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,839 | $12K |
| 73610 | <1% | 633 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,237 | $12K |
| 87040 | <1% | 1,247 | $11K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 68 | $11K |
| 97162 | <1% | 253 | $11K | |
| 72100 | <1% | 352 | $10K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 99 | $10K |
| 0012A | <1% | 257 | $9K | |
| 84702 | <1% | 1,100 | $9K | |
| 83880 | <1% | 1,425 | $9K | |
| 73030 | <1% | 416 | $8K | |
| 87077 | <1% | 3,497 | $8K | |
| 87186 | <1% | 2,734 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 711 | $8K |
| 0011A | <1% | 279 | $7K | |
| 97161 | <1% | 193 | $7K | |
| 86803 | <1% | 1,196 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,738 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,064 | $6K |
| 90837 | Psychotherapy session, about an hour | <1% | 546 | $6K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 55 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,691 | $6K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 644 | $6K |
| 83690 | <1% | 6,433 | $6K | |
| 73130 | <1% | 270 | $6K | |
| 86140 | <1% | 1,423 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 293 | $5K |
| 80305 | <1% | 2,374 | $5K | |
| 76642 | <1% | 62 | $5K | |
| 81025 | <1% | 4,244 | $5K | |
| 82728 | <1% | 628 | $4K | |
| 97116 | <1% | 344 | $4K | |
| 85610 | <1% | 3,883 | $4K | |
| 83735 | <1% | 2,574 | $4K | |
| 81001 | <1% | 3,662 | $4K | |
| 84481 | <1% | 430 | $4K | |
| 81003 | <1% | 7,231 | $4K | |
| 73110 | <1% | 215 | $4K | |
| 87420 | <1% | 1,364 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 50 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 948 | $3K |
| 82607 | <1% | 464 | $3K | |
| 85379 | <1% | 518 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,897 | $3K |
| 87653 | <1% | 187 | $3K | |
| 81002 | <1% | 1,870 | $3K | |
| 76801 | <1% | 69 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,633 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 683 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 118 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,584 | $3K |
| 85651 | <1% | 1,013 | $3K | |
| 82550 | <1% | 3,237 | $3K | |
| 87205 | <1% | 1,717 | $3K | |
| 83550 | <1% | 561 | $3K | |
| 82570 | <1% | 925 | $2K | |
| 93971 | <1% | 25 | $2K | |
| 82553 | <1% | 722 | $2K | |
| 87147 | <1% | 1,299 | $2K | |
| 0031A | <1% | 72 | $2K | |
| 85018 | <1% | 678 | $2K | |
| 85730 | <1% | 2,589 | $2K | |
| 83540 | <1% | 574 | $2K | |
| 97010 | <1% | 145 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 14 | $2K |
| 86900 | <1% | 1,415 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,199 | $1K |
| 85014 | <1% | 370 | $1K | |
| 85027 | <1% | 351 | $1K | |
| 86787 | <1% | 274 | $1K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 112 | $1K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 32 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,646 | $1K |
| 87210 | <1% | 398 | $1K | |
| 87634 | <1% | 59 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,862 | $1K |
| 82043 | <1% | 529 | $1K | |
| 80055 | <1% | 201 | $1K | |
| 86850 | <1% | 1,190 | $1K | |
| 93017 | <1% | 14 | $942.42 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,246 | $941.73 |
| 82962 | <1% | 942 | $916.50 | |
| 96376 | <1% | 1,212 | $899.71 | |
| 74018 | <1% | 55 | $887.75 | |
| 86695 | <1% | 60 | $774.54 | |
| 86901 | <1% | 1,414 | $763.00 | |
| 0002A | <1% | 17 | $759.60 | |
| 86703 | <1% | 223 | $711.29 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 43 | $697.38 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 577 | $683.45 |
| 94060 | <1% | 13 | $626.60 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 529 | $623.29 |
| 90715 | <1% | 37 | $605.75 | |
| 73502 | <1% | 25 | $601.48 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 551 | $599.33 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 160 | $585.91 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,531 | $560.88 |
| 0001A | <1% | 15 | $520.91 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 37 | $453.77 |
| 86696 | <1% | 60 | $376.31 | |
| 82950 | <1% | 98 | $330.68 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 35 | $322.31 |
| 94729 | <1% | 13 | $318.70 | |
| 94726 | <1% | 12 | $313.31 | |
| 80076 | <1% | 69 | $306.02 | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 44 | $272.31 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 455 | $213.75 |
| 81015 | <1% | 3,073 | $202.99 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 40 | $195.84 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 292 | $167.79 |
| 84403 | <1% | 25 | $163.03 | |
| 82105 | <1% | 15 | $131.84 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 226 | $106.08 |
| 74022 | <1% | 30 | $104.03 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 18 | $95.76 |
| 83001 | <1% | 12 | $82.92 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 13 | $77.66 |
| 51798 | <1% | 31 | $72.06 | |
| 87075 | <1% | 18 | $48.76 | |
| 36591 | <1% | 23 | $46.58 | |
| 84703 | <1% | 79 | $45.84 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 175 | $40.10 |
| 36592 | <1% | 103 | $28.34 | |
| 82150 | <1% | 31 | $23.18 | |
| J3490 | Unclassified drugs | <1% | 823 | $18.97 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $13.71 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 18 | $5.41 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 76 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 15 | $0.00 |
| 99152 | 0% | 17 | $0.00 | |
| 91300 | 0% | 17 | $0.00 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 15 | $0.00 |
| 85007 | 0% | 13 | $0.00 | |
| 96367 | 0% | 13 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 5,334 | $0.00 |
| 91303 | 0% | 69 | $0.00 | |
| 91301 | 0% | 532 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 131 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 15 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCUTTER, ELISE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Public Hospital District No 2 Skagit County Washington | Anacortes, WA | $5.79M |
| Public Hospital District No 2 Skagit County Washington | Anacortes, WA | $4.76M |
| Public Hospital District No 2 Skagit County Washington | Eastsound, WA | $1.24M |
| Public Hospital District No 2 Skagit County Washington | Anacortes, WA | $501K |
| Public Hospital District No 2 Skagit County Washington | Anacortes, WA | $262K |
| Public Hospital District No 2 Skagit County Washington | Anacortes, WA | $32K |
| Public Hospital District No 2 Skagit County Washington | Anacortes, WA | $10K |
| Public Hospital District No 2 Skagit County Washington | Eastsound, WA | $6K |
| Public Hospital District No 2 Skagit County Washington | Anacortes, WA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.